09 October 2003 /Prices and reimbursement
This study sheds light on the development of the use of medicinal products for Alzheimer's disease during the period September 1997 until April 2003. Four medicinal products are used for treating Alzheimer's disease - 3 cholinesterase inhibitors (Aricept®, Exelon® and Reminyl®) and a glutamine
30 September 2003 /Prices and reimbursement
Since Spiriva® was introduced on the market in the second quarter of 2002, there has been a great increase in both the consumption and prevalence of the agent among the elderly.
22 May 2003 /Prices and reimbursement
The purpose of the present investigation is to shed light on the variations in pharmaceutical companies' market shares at individual pharmacies and to investigate whether these differences mean that the dispense practice is inappropriate or expensive.
01 April 2003 /Prices and reimbursement
This analysis indicates that hoarding is a problem within the need-dependent reimbursement system. Among medicine users with expenses exceeding DKK 510 within a reimbursement year, hoarding is estimated to constitute approximately 2 per cent of the users' reimbursable medicine expenses.